SWM
ABBV icon

Spire Wealth Management’s AbbVie ABBV Stock Holding History

Spire Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.3M Buy
13,113
+1,188
+10% +$256K 0.1% 183
2026
Q1 		$2.59M Buy
11,925
+580
+5% +$129K 0.09% 209
2025
Q4 		$2.59M Buy
11,345
+196
+2% +$44.6K 0.09% 207
2025
Q3 		$2.58M Sell
11,149
-642
-5% -$131K 0.09% 189
2025
Q2 		$2.19M Sell
11,791
-13,508
-53% -$2.51M 0.08% 213
2025
Q1 		$5.3M Buy
25,299
+26
+0.1% +$5.05K 0.17% 115
2024
Q4 		$4.49M Sell
25,273
-1,474
-6% -$271K 0.14% 137
2024
Q3 		$5.28M Buy
26,747
+494
+2% +$92.2K 0.18% 114
2024
Q2 		$4.5M Sell
26,253
-1,100
-4% -$182K 0.16% 132
2024
Q1 		$4.98M Sell
27,353
-2,886
-10% -$497K 0.09% 161
2023
Q4 		$4.98M Sell
30,239
-28,814
-49% -$4.2M 0.16% 142
2023
Q3 		$8.8M Buy
59,053
+25,536
+76% +$3.75M 0.34% 65
2023
Q2 		$4.52M Sell
33,517
-2,056
-6% -$301K 0.17% 117
2023
Q1 		$5.67M Buy
35,573
+12,360
+53% +$1.89M 0.22% 103
2022
Q4 		$3.75M Buy
23,213
+4,682
+25% +$718K 0.21% 106
2022
Q3 		$2.49M Sell
18,531
-34,292
-65% -$4.92M 0.15% 125
2022
Q2 		$8.09M Sell
52,823
-7,967
-13% -$1.22M 0.33% 75
2022
Q1 		$9.86M Sell
60,790
-16,109
-21% -$2.34M 0.26% 105
2021
Q4 		$10.4M Buy
76,899
+11,214
+17% +$1.32M 0.23% 115
2021
Q3 		$7.08M Sell
65,685
-3,038
-4% -$347K 0.19% 131
2021
Q2 		$7.73M Sell
68,723
-16,214
-19% -$1.83M 0.21% 126
2021
Q1 		$8.81M Buy
+84,937
New +$9.09M 0.23% 113

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Spire Wealth Management's ABBV Position: Q2 2026 in Review

Spire Wealth Management increased its AbbVie (ABBV) stake by 10% in Q2 2026, buying an estimated $256K and bringing the position to 13,113 shares worth $3.3M. The position accounts for 0.1% of the portfolio, ranked #183.

Spire Wealth Management first reported a position in ABBV in Q1 2021 and has held it in 22 quarters since. The position peaked at $10.4M in Q4 2021. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Spire Wealth Management held 13,113 shares of AbbVie worth $3.3M as of Q2 2026.
  • Spire Wealth Management bought 1,188 AbbVie shares in Q2 2026, an estimated $256K.
  • AbbVie made up 0.1% of Spire Wealth Management's portfolio in Q2 2026, its #183 holding.
  • Spire Wealth Management first reported a position in AbbVie in Q1 2021 and has held it in 22 quarters since.
  • Spire Wealth Management's AbbVie position peaked at $10.4M in Q4 2021.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Spire Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.